Executive Function Performance in Children Who Stutter

December 6, 2022 updated by: Rasha Mohamed Hashem, Sohag University
The study aims to asses the executive function in children who stutter for better management of those children

Study Overview

Status

Not yet recruiting

Detailed Description

It is a case control study which will be done on 30 child who stutter and 15 normal child as a control group. Executive function testing will be done using computerized program called PEPL . Also, total intelligence quation(IQ) , verbal IQ, non verbal IQ will be assessed in both groups. stuttering severity will be assessed in case group.

Study Type

Observational

Enrollment (Anticipated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

30 case group, 15 control group age range 7 yrs old and 15 yrs old

Description

Inclusion Criteria:

  1. Patient and volunteers age between 7 years and 15 years.
  2. IQ ≥ 85.

Exclusion Criteria:

  • History of secondary stuttering.
  • Language impairment and other speech problem.
  • Concurrent or history of psychiatric, cognitive, neurological disorders or hearing impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
children who stutter
assessment executive function and stuttering severity in 30 child with stuttering
Assessment of executive function subdivision
children who don't stutter
assessment executive function in 30 child with stuttering
Assessment of executive function subdivision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PEPL numerical stroop test
Time Frame: one year
Using the Psychological Experimental Building Language (PEBL) current version 2.1 released at 2018 (Muller & Piper, 2014). The test measuring inhibitory function It asses the reaction time in seconds, the total numbers of errors ranging between 0-200
one year
Cognitive flexibility function (sub-division of executive function testing)
Time Frame: one year
PEPL Berg's Card Sorting Test 64 version of Berg's (1948) Wisconsin Card Sorting Test. The child is asked to sort multi-attribute cards into piles according to an unknown and changing rule. It provides an indication of which rule (shape, color or number) is easiest for the individual. It aims to asses Number of Correct Responses: ranging between 0-64 Number of Total Errors ranging between 0-64 Percent of Perseverative Responses Percent of Perseverative Errors Percent of Non-Perseverative Errors Number of Unique Errors
one year
Working memory score
Time Frame: one year
Sub-test of Stanford-Binet Intelligence Scales, 5th Edition (SB5) The score ranging between 40-130
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non word Repetation score(Fawzy et al., 2012)
Time Frame: one year
To test the working memory abilities. the child is asked to repeat a number of non sense words. The score ranges between 0 to 30
one year
Backward digit span score (Aboras et al., 2008)
Time Frame: one year
It test the working memory. The child is asked to retell a number of digit in backward manner. The score ranges between 0 to 14.
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ahlam A Nabieh, professor, ahlaama@yahoo.com

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2022

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

July 1, 2024

Study Registration Dates

First Submitted

November 16, 2022

First Submitted That Met QC Criteria

December 6, 2022

First Posted (Estimate)

December 7, 2022

Study Record Updates

Last Update Posted (Estimate)

December 7, 2022

Last Update Submitted That Met QC Criteria

December 6, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Executive Dysfunction

Clinical Trials on Executive function testing

Subscribe